Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
1(8%)
Results Posted
40%(4 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_1
7
54%
Ph phase_3
1
8%
Ph not_applicable
2
15%
Ph phase_2
3
23%

Phase Distribution

7

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
7(53.8%)
Phase 2Efficacy & side effects
3(23.1%)
Phase 3Large-scale testing
1(7.7%)
N/ANon-phased studies
2(15.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

10 of 12 finished

Non-Completion Rate

16.7%

2 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(1)
Completed(10)
Terminated(2)

Detailed Status

Completed10
Recruiting1
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
90.9%
Most Advanced
Phase 3

Trials by Phase

Phase 17 (53.8%)
Phase 23 (23.1%)
Phase 31 (7.7%)
N/A2 (15.4%)

Trials by Status

completed1077%
recruiting18%
terminated18%
withdrawn18%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials
NCT05781399Phase 1

First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With Phenylketonuria

Completed
NCT05714085Phase 2

Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

Recruiting
NCT04493671Phase 1

Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults

Completed
NCT03758612Phase 1

A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of TBI-223 in Healthy Adults

Completed
NCT06260267Phase 1

A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis

Withdrawn
NCT02389998Not Applicable

Efficacy of Open Label Placebo in Children With FGIDs

Completed
NCT02119260Phase 2

A First Time in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Healthy Subjects and Stable Heart Failure Patients

Completed
NCT01340690Phase 3

Efficacy Study of Polyunsaturated Fatty Acids in Children and Adolescents With Attention Deficit/ Hyperactivity Disorder

Terminated
NCT00727740Not Applicable

A Double-blind Study to Determine if Intraduodenal Indomethacin Can Decrease the Incidence of Post-ERCP Pancreatitis

Completed
NCT02755064Phase 1

Relationship Between Gastric Emptying and Glycemic Variability in Type 1 Diabetes Mellitus

Completed
NCT00669227Phase 2

Intracoronary Stem Cell Therapy in Patients With Acute Myocardial Infarction (SCAMI)

Completed
NCT01127906Phase 1

Study To Assess The Effect Of PF-04531083 On Heat Pain In Healthy Volunteers With Ultraviolet Light Sensitized Skin

Completed
NCT00996021Phase 1

Study to Assess Cardiac Conduction of GSK1349572

Completed

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13